Kintz P
X-Pertise Consulting, 42, rue principale, 67206 Mittelhausbergen, France.
Institut de médecine légale, 11, rue Humann, 67000 Strasbourg, France.
Bull Acad Natl Med. 2020 Jun;204(6):577-582. doi: 10.1016/j.banm.2020.04.003. Epub 2020 Apr 16.
Among the 60 or so various cannabinoids which are present in , terpenophenols are mainly found, including delta-9-trans tetrahydrocannabinol (Δ9-THC) which is the major psychoactive ingredient. Over the last decade, due to the emergence of e-commerce and the continuous investigations by pharmaceutical groups to identify new active molecules, synthetic cannabinoids have been proposed. These compounds, under the generic name "spices" have chemical structures very different from that of Δ9-THC, but share the same CB1 and CB2 receptors. They are mimics of Δ9-THC with much powerful pharmacological effects, including thus more deterrent side-effects, and enhanced windows of detection. All these drugs are controlled. This means that they have to be tested in human biological specimens to document abuse. The aim of this mini-review is to present what has been described in the scientific literature according to the available specimens (blood, urine, saliva, sweat, hair and exhaled breath), focussing on the current advantages and limitations of each test.
在大麻中存在的约60种不同的大麻素中,主要发现的是萜酚类化合物,包括δ-9-反式四氢大麻酚(Δ9-THC),它是主要的精神活性成分。在过去十年中,由于电子商务的兴起以及制药集团不断进行研究以鉴定新的活性分子,合成大麻素被提出。这些化合物以“香料”的通用名称命名,其化学结构与Δ9-THC非常不同,但共享相同的CB1和CB2受体。它们是Δ9-THC的模拟物,具有更强的药理作用,包括更具威慑力的副作用和更长的检测窗口期。所有这些药物都受到管制。这意味着必须在人体生物样本中进行检测以记录滥用情况。本综述的目的是根据现有样本(血液、尿液、唾液、汗液、毛发和呼出气体)介绍科学文献中所描述的内容,重点关注每种检测方法当前的优点和局限性。